InvestorPlace2/23/21, 08:05 PMAn analyst upgrade is the near-term catalyst, but for $SNSS, it's really about patents and a merger with Viracta. investorplace.com/2021/02/s...SNSS Stock: Why Sunesis Pharmaceuticals Is Soaring Todayvia: InvestorPlace33 Likes